2
POPSThe Benefits of L-Methylfolate in Treating Folic Acid Deficiency Aan extremely highly absorbable form of Folic Acid (also known as Folate) called L-Methylfolate, which can help offset polymorphisms and mutated genes that inhibit one's ability to metabolize Folic Acid. Anyone with elevated homocysteine levels or who has had elevated homocysteine levels should be checked to see if the polymorphism is present. In these affected individuals, supplementation with L-Methylfolate may help reduce the risk of an entire array of diseases, including Alzheimer's, cancer, heart disease, stroke, coronary artery disease, and more.
3
POPSWhy antidepressants don't work for so many people More: The biochemical events that ultimately result in depression actually start in the development and functioning of neurons. "The medications have been focusing on the effect, not the cause," she said. "That's why it takes so long for them to work and why they aren't effective for so many people." Her animal model of depression did not show dramatic differences in the levels of genes controlling neurotransmitters functions. "If depression was related to neurotransmitter activity, we would have seen that," she said. Her findings in depressed rats, she said, are very likely applicable to humans. "The similarities between these regions of the human and rodent brain are remarkable," Redei explained. "The hippocampus and amygdala are part of the so-called ancient lizard brain that controls survival and are the same in even primitive organisms."
4
POPS31 Sneaky Mood Boosters Want to feel happier today, tomorrow and for the rest of your life? Okay, okay, dumb question — of course you do!
7
POPSHow Big Pharma pushed a more-expensive, no-more-effective drug
More: Lexapro had $2.3 billion in sales in 2008 even though generic versions of Celexa and every other drug in the class sell for a fraction of Lexapro’s price. For example, a month’s supply of 5-milligram tablets of Lexapro costs $87.99 at drugstore.com, compared to $14.99 for a month’s supply of a generic version of Prozac. Forest has recently been raising the price of Lexapro to make up for a decline in its use… It is impossible to unpack all of the reasons for these prescriptions, but some industry critics say one reason could be the money doctors make from Forest. Psychiatrists make more money from drug makers than any other medical specialty, according to analyses of payment data. And Forest gives more money and food to doctors than many of its far larger rivals… Forest’s payments to doctors in 2008 were surpassed only by those of Eli Lilly, Pfizer, Novartis and Merck — companies with annual sales that are five to 10 times larger than Forest’s.
5
POPSCentral Control of Your Doctor and Your Health!
The House bill calls for this appointed board, dubbed the Federal Coordinating Council for Comparative Effectiveness Research, to be at least 50 percent "physicians or other experts with clinical expertise." However, there is no way the Council's 15 members - all of whom also must be employed in federal government agencies - can determine which drug or treatment is going to work . You are a unique human being, with genetic and environmental factors influencing your health. Your sister has severe depression, and she responds only to one antidepressant. What if it isn't the one that works for most people? Or it's the most expensive one? Peter Pitts, head of the Center for Medicine in the Public Interest and a former FDA associate commissioner, explained why "one-size-fits-all" medicine doesn't work: Most comparative effectiveness studies "don't capture the genetic variations that explain differences in response to medicines by different patients."
0
POPSMandated Mental Screening for Pregnant Women, Babies & Toddlers The points are simple: The Mothers Act is a bill which will increase mental health screening of pregnant women and new mothers, despite the fact that the widely accepted treatment for women diagnosed with postpartum depression is antidepressant drugs — documented by the U.S. FDA to cause worsening depression, mania, psychosis, suicidal and homicidal ideation and birth defects. There is no language in the bill that would assure mothers are given non-drug options or accurate information about the subjectivity of the diagnoses (a checklist of questions) or the documented risks of psychiatric drugs. This violates informed consent and puts new mothers and their infants at risk. Messages to members of Congress that are short, concise and to the point are the best. CCHR International
6
Pops
Newest Clips
Latest Comments
Most Pops
Print
Save
Turn on live update